Fri, May 3, 2024
Thu, May 2, 2024
Wed, May 1, 2024

Hartaj Singh Maintained (UTHR) at Buy with Increased Target to $400 on, May 2nd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-400-on-may-2nd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Hartaj Singh of Oppenheimer, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $375 to $400 on, May 2nd, 2024.

Hartaj has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 1 agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $215 on, Monday, February 12th, 2024


These are the ratings of the 3 analyists that currently disagree with Hartaj


  • Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $325 on, Thursday, March 7th, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024

Publication Contributing Sources